Literature DB >> 11458278

Heat shock protein 60 in corpora amylacea.

I Gáti1, L Leel-Ossy.   

Abstract

Heat shock protein 60 representation in the corpora amylacea of the brain was investigated in five different neurological diseases. In the cases with cerebral infarct, amyotrophic lateral sclerosis, multiple sclerosis, acute disseminated encephalomyelitis and primary tumors of the nervous system the corpora amylacea showed similar appearance with strong HSP-60 positivity in all investigated disorders at the predilection sites. In the inflammatory diseases, besides corpora amylacea, several cellular elements exhibited HSP-60 immunostaining too. In these cases, the widespread HSP-60 immunoreactivity associated with relative moderate corpora amylacea production as compared to other diseases. From this contradiction we concluded the corpora amylacea participate in the cellular stress reaction but stress protein synthesis certainly is not the primary event in corpora amylacea formation. In the development of the corpora amylacea the incipient process is most probably degenerative in nature, which later on is accompanied by stress protein synthesis and slow growing of these round structures designated for a protective role in the brain. However, the role of the stress protein synthesis in the corpora amylacea formation and growth was not unequivocally answered in this study. It is necessary to perform further comparative investigations of the stress protein representation and corpora amylacea formation in different diseases which may help in discovering useful pathogenetic data and the biological role of this degenerative structure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458278     DOI: 10.1007/BF03032581

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  19 in total

1.  Protein folding in mitochondria requires complex formation with hsp60 and ATP hydrolysis.

Authors:  J Ostermann; A L Horwich; W Neupert; F U Hartl
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

2.  Ubiquitin and heat shock protein expression in amyotrophic lateral sclerosis.

Authors:  O Garofalo; P G Kennedy; M Swash; J E Martin; P Luthert; B H Anderton; P N Leigh
Journal:  Neuropathol Appl Neurobiol       Date:  1991-02       Impact factor: 8.090

Review 3.  Induction of heat shock protein synthesis by prostaglandins with antineoplastic and antiviral activity.

Authors:  M G Santoro; E Garaci; C Amici
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1991

4.  Abnormal proteins serve as eukaryotic stress signals and trigger the activation of heat shock genes.

Authors:  J Ananthan; A L Goldberg; R Voellmy
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

Review 5.  Stress (heat shock) protein accumulation in the central nervous system. Its relationship to cell stress and damage.

Authors:  M Tytell; M F Barbe; I R Brown
Journal:  Adv Neurol       Date:  1993

Review 6.  The ubiquitin-mediated proteolytic pathway.

Authors:  A Ciechanover
Journal:  Brain Pathol       Date:  1993-01       Impact factor: 6.508

7.  Relationships between stress protein induction and NMDA-mediated neuronal death in the entorhinal cortex.

Authors:  W M Yee; D M Frim; O Isacson
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

8.  Heat shock protein immunoreactivity in CSF: correlation with oligoclonal banding and demyelinating disease.

Authors:  S Prabhakar; E Kurien; R S Gupta; S Zielinski; M S Freedman
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

Review 9.  The roles of heat shock proteins and immediate early genes in central nervous system normal function and pathology.

Authors:  M Chopp
Journal:  Curr Opin Neurol Neurosurg       Date:  1993-02

10.  Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors.

Authors:  K V Lukacs; D B Lowrie; R W Stokes; M J Colston
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  7 in total

1.  Localization of blood proteins thrombospondin1 and ADAMTS13 to cerebral corpora amylacea.

Authors:  He Meng; Xiaojie Zhang; Mila Blaivas; Michael M Wang
Journal:  Neuropathology       Date:  2009-04-28       Impact factor: 1.906

Review 2.  Mitochondrial chaperones in human health and disease.

Authors:  Tyler Bahr; Joshua Katuri; Ting Liang; Yidong Bai
Journal:  Free Radic Biol Med       Date:  2021-11-12       Impact factor: 7.376

3.  New perspectives on corpora amylacea in the human brain.

Authors:  Elisabet Augé; Itsaso Cabezón; Carme Pelegrí; Jordi Vilaplana
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

4.  Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organelles.

Authors:  Paula P Navarro; Christel Genoud; Daniel Castaño-Díez; Alexandra Graff-Meyer; Amanda J Lewis; Yvonne de Gier; Matthias E Lauer; Markus Britschgi; Bernd Bohrmann; Stephan Frank; Jürgen Hench; Gabriel Schweighauser; Annemieke J M Rozemuller; Wilma D J van de Berg; Henning Stahlberg; Sarah H Shahmoradian
Journal:  Sci Rep       Date:  2018-12-21       Impact factor: 4.379

5.  Lipopolysaccharide, Identified Using an Antibody and by PAS Staining, Is Associated With Corpora amylacea and White Matter Injury in Alzheimer's Disease and Aging Brain.

Authors:  Xinhua Zhan; Marisa Hakoupian; Lee-Way Jin; Frank R Sharp
Journal:  Front Aging Neurosci       Date:  2021-11-24       Impact factor: 5.750

6.  Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate.

Authors:  Kiran Yanamandra; Oleg Alexeyev; Vladimir Zamotin; Vaibhav Srivastava; Andrei Shchukarev; Ann-Christin Brorsson; Gian Gaetano Tartaglia; Thomas Vogl; Rakez Kayed; Gunnar Wingsle; Jan Olsson; Christopher M Dobson; Anders Bergh; Fredrik Elgh; Ludmilla A Morozova-Roche
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

7.  Exploring the elusive composition of corpora amylacea of human brain.

Authors:  Elisabet Augé; Jordi Duran; Joan J Guinovart; Carme Pelegrí; Jordi Vilaplana
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.